Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.

PloS one - 1 Jan 2012

Rossi Francesca, Bellini Giulia, Alisi Anna, Alterio Arianna, Maione Sabatino, Perrone Laura, Locatelli Franco, Miraglia del Giudice Emanuele, Nobili Valerio

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simple steatosis to inflammatory steatohepatitis (NASH) with different degrees of fibrosis that can ultimately progress to cirrhosis. Accumulating evidence suggests the involvement of the endocannabinoid-system in liver disease and related complications. In particular, hepatoprotective properties for Cannabinoid Receptor type 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Non-alcoholic Fatty Liver Disease

Share to Receptor, Cannabinoid, CB2

Source

Open in PubMed Open full text

Identifiers

PMID: 22927922
DOI: 10.1371/journal.pone.0042259
PMCID: PMC3426511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.PMID 22927922Read ↗

Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.Semantic proximity Read ↗

Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.Semantic proximity Read ↗

Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation.Semantic proximity Read ↗

Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease.Semantic proximity Read ↗

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.Semantic proximity Read ↗

Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.Semantic proximity Read ↗

No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.Semantic proximity Read ↗

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.Semantic proximity Read ↗

Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.Semantic proximity Read ↗

Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.Semantic proximity Read ↗

Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System.Semantic proximity Read ↗

Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.